HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy.
Saved in:
| Title: | HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy. |
|---|---|
| Authors: | Nelde, Annika1,2, Kowalewski, Daniel J.1,3, Backert, Linus1,4, Schuster, Heiko1,3, Werner, Jan-Ole2, Klein, Reinhild2, Kohlbacher, Oliver4,5,6, Kanz, Lothar2, Salih, Helmut R.2,7, Rammensee, Hans-Georg1,8, Stevanović, Stefan1,8, Walz, Juliane S.2 juliane.walz@med.uni-tuebingen.de |
| Source: | OncoImmunology. Apr2018, Vol. 7 Issue 4, p1-12. 12p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 128898687 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Nelde%2C+Annika%22">Nelde, Annika</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Kowalewski%2C+Daniel+J%2E%22">Kowalewski, Daniel J.</searchLink><relatesTo>1,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Backert%2C+Linus%22">Backert, Linus</searchLink><relatesTo>1,4</relatesTo><br /><searchLink fieldCode="AR" term="%22Schuster%2C+Heiko%22">Schuster, Heiko</searchLink><relatesTo>1,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Werner%2C+Jan-Ole%22">Werner, Jan-Ole</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Klein%2C+Reinhild%22">Klein, Reinhild</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Kohlbacher%2C+Oliver%22">Kohlbacher, Oliver</searchLink><relatesTo>4,5,6</relatesTo><br /><searchLink fieldCode="AR" term="%22Kanz%2C+Lothar%22">Kanz, Lothar</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Salih%2C+Helmut+R%2E%22">Salih, Helmut R.</searchLink><relatesTo>2,7</relatesTo><br /><searchLink fieldCode="AR" term="%22Rammensee%2C+Hans-Georg%22">Rammensee, Hans-Georg</searchLink><relatesTo>1,8</relatesTo><br /><searchLink fieldCode="AR" term="%22Stevanović%2C+Stefan%22">Stevanović, Stefan</searchLink><relatesTo>1,8</relatesTo><br /><searchLink fieldCode="AR" term="%22Walz%2C+Juliane+S%2E%22">Walz, Juliane S.</searchLink><relatesTo>2</relatesTo><i> juliane.walz@med.uni-tuebingen.de</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22OncoImmunology%22">OncoImmunology</searchLink>. Apr2018, Vol. 7 Issue 4, p1-12. 12p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=128898687 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/2162402X.2017.1316438 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 1 Titles: – TitleFull: HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nelde, Annika – PersonEntity: Name: NameFull: Kowalewski, Daniel J. – PersonEntity: Name: NameFull: Backert, Linus – PersonEntity: Name: NameFull: Schuster, Heiko – PersonEntity: Name: NameFull: Werner, Jan-Ole – PersonEntity: Name: NameFull: Klein, Reinhild – PersonEntity: Name: NameFull: Kohlbacher, Oliver – PersonEntity: Name: NameFull: Kanz, Lothar – PersonEntity: Name: NameFull: Salih, Helmut R. – PersonEntity: Name: NameFull: Rammensee, Hans-Georg – PersonEntity: Name: NameFull: Stevanović, Stefan – PersonEntity: Name: NameFull: Walz, Juliane S. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: Apr2018 Type: published Y: 2018 Identifiers: – Type: issn-print Value: 21624011 Numbering: – Type: volume Value: 7 – Type: issue Value: 4 Titles: – TitleFull: OncoImmunology Type: main |
| ResultId | 1 |